Federal rules around compounding can change depending on drug availability, patient-specific medical need, pharmacy type, and FDA enforcement priorities
Altered Food Preferences: Some individuals report changes in taste perception, particularly a reduced preference for fatty and highly processed foods, suggesting GLP-1 medications reshape dietary behavior beyond just appetite suppression
The combined result is a synergistic triple-pathway metabolic effect that surpasses any single or dual-agonist approach in clinical research outcomes
Berberine, a bioactive alkaloid derived from various plants, including Berberis species, has garnered significant attention as a nutraceutical agent due to its potential benefits in metabolic health
Retatrutide is a next-generation triple agonist peptide targeting the GIP (glucose-dependent insulinotropic polypeptide) , GLP-1 (glucagon-like peptide-1) , and glucagon receptors
I wrote a non-zero amount, but also not as much as I would have liked